Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877638 · ClinicalTrials.gov registry record · NA
SWC for Treatment of Superficial Partial-Thickness Burns
A NA study, sponsored by Synedgen.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT05877638 is a NA study that was terminated before completion, run by Synedgen. The registered enrollment target is 2 participants.
The verdict
NCT05877638, a NA study, was terminated before completion, sponsored by Synedgen.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to test the safety and effectiveness of SynePure™ Wound Cleanser when used in combination with Catasyn™ Advanced Technology Hydrogel for the treatment of superficial partial-thickness burn wounds.
Interventions
- DEVICE SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel
- DRUG SILVADENE Cream 1% (silver sulfadiazine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2024-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05877638
The ClinicalTrials.gov registry entry for NCT05877638 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Synedgen, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel is the first listed.
NCT05877638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05877638 about?
NCT05877638 is a clinical study titled "SWC for Treatment of Superficial Partial-Thickness Burns". The purpose of this study is to test the safety and effectiveness of SynePure™ Wound Cleanser when used in combination with Catasyn™ Advanced Technology Hydrogel for the treatment of superficial partial-thickness burn wounds.
What is the current status of trial NCT05877638?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2023-03-27. Estimated completion is 2024-06-20.
What interventions are being tested in trial NCT05877638?
The interventions under investigation include: SynePure Wound Cleanser and Catasyn Advanced Technology Hydrogel (DEVICE), SILVADENE Cream 1% (silver sulfadiazine) (DRUG).
Who is sponsoring clinical trial NCT05877638?
This trial is sponsored by Synedgen, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.